Piramal Healthcare Uk Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is MISOPROSTOL DISPERSION, with a corresponding US DMF Number 21188.
Remarkably, this DMF maintains an Active status since its submission on December 12, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 07, 2013, and payment made on January 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II